Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? : Drug Development: What Experience Has Taught UsNECKERS, Len; WORKMAN, Paul.Clinical cancer research (Print). 2012, Vol 18, Num 1, pp 64-76, issn 1078-0432, 13 p.Article

Heat Shock Protein 90 Inhibitors: New Mode of Therapy to Overcome Endocrine ResistanceWONG, Cynthie; SHIUAN CHEN.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 22, pp 8670-8677, issn 0008-5472, 8 p.Article

Molecular Pathways: Targeting Hsp90—Who Benefits and Who Does NotSCALTRITI, Maurizio; DAWOOD, Shaheenah; CORTES, Javier et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4508-4513, issn 1078-0432, 6 p.Article

Efungumab: A Novel Agent in the Treatment of Invasive CandidiasisKARWA, Rakhi; WARGO, Kurt A.The Annals of pharmacotherapy. 2009, Vol 43, Num 11, pp 1818-1823, issn 1060-0280, 6 p.Article

Type 1 diabetes alters anti-HSP90 autoantibody isotypeQIN, Hui-Yu; MAHON, Jeffrey L; ATKINSON, Mark A et al.Journal of autoimmunity (Print). 2003, Vol 20, Num 3, pp 237-245, issn 0896-8411, 9 p.Article

Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxideKONE, Bruce C; KUNCEWICZ, Teresa; WENZHENG ZHANG et al.American journal of physiology. Renal physiology. 2003, Vol 54, Num 2, pp F178-F190, issn 1931-857XArticle

Stressing the Development of Small Molecules Targeting HSP90NECKERS, Len; TREPEL, Jane B.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 275-277, issn 1078-0432, 3 p.Article

Harmine Is a Potent Antimalarial Targeting Hsp90 and Synergizes with Chloroquine and ArtemisininSHAHINAS, Dea; MACMULLIN, Gregory; BENEDICT, Christan et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 8, pp 4207-4213, issn 0066-4804, 7 p.Article

JNK1 Mediates Degradation HIF-1α by a VHL-Independent Mechanism that Involves the Chaperones Hsp90/Hsp70DONGYUN ZHANG; JINGXIA LI; COSTA, Max et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 2, pp 813-823, issn 0008-5472, 11 p.Article

Enzymatic Reduction and Glutathione Conjugation of Benzoquinone Ansamycin Heat Shock Protein 90 Inhibitors : Relevance for Toxicity and Mechanism of ActionWENCHANG GUO; REIGAN, Philip; SIEGEL, David et al.Drug metabolism and disposition. 2008, Vol 36, Num 10, pp 2050-2057, issn 0090-9556, 8 p.Article

Antitumor Activity of SNX-2112, a Synthetic Heat Shock Protein-90 Inhibitor, in MET-Amplified Tumor Cells with or without Resistance to Selective MET InhibitionBACHLEITNER-HOFMANN, Thomas; SUN, Mark Y; SOLIT, David B et al.Clinical cancer research (Print). 2011, Vol 17, Num 1, pp 122-133, issn 1078-0432, 12 p.Article

Heat Shock Protein 90 Inhibition Depletes LATS1 and LATS2, Two Regulators of the Mammalian Hippo Tumor Suppressor PathwayHUNTOON, Catherine J; NYE, Monica D; LIYI GENG et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 21, pp 8642-8650, issn 0008-5472, 9 p.Article

Characterization of the combined cellular survival effects of benzoquinone-ansamycins and ionizing radiationOCHEL, Hans-Joachim; GADEMANN, Gunther.Journal of cancer research and clinical oncology. 2005, Vol 131, Num 5, pp 323-328, issn 0171-5216, 6 p.Article

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivativeHOLLINGSHEAD, Melinda; ALLEY, Michael; BURGER, Angelika M et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 2, pp 115-125, issn 0344-5704, 11 p.Article

Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2⁺ Tumor Cell Recognition by Specific CD8⁺ T CellsKAWABE, Mayumi; MANDIC, Maja; TAYLOR, Jennifer L et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 17, pp 6995-7003, issn 0008-5472, 9 p.Article

Silencing of HSP90 Cochaperone AHA1 Expression Decreases Client Protein Activation and Increases Cellular Sensitivity to the HSP90 Inhibitor 17-Allylamino-17-DemethoxygeldanamycinHOLMES, Joanna L; SHARP, Swee Y; HOBBS, Steve et al.Cancer research (Baltimore). 2008, Vol 68, Num 4, pp 1187-1196, issn 0008-5472, 10 p.Article

Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2TANAKA, Karo; ESKIN, Ascia; NELSON, Stanley F et al.Clinical cancer research (Print). 2013, Vol 19, Num 14, pp 3856-3870, issn 1078-0432, 15 p.Article

Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cellsRAO, Aparna; TAYLOR, Jennifer L; CHI-SABINS, Nina et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 13, pp 3196-3206, issn 0008-5472, 11 p.Article

The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse MechanismsPARAISO, Kim H. T; HAARBERG, H. Eirik; JOHN, Jobin K et al.Clinical cancer research (Print). 2012, Vol 18, Num 9, pp 2502-2514, issn 1078-0432, 13 p.Article

Molecular Imaging of the Efficacy of Heat Shock Protein 90 Inhibitors in Living SubjectsCHAN, Carmel T; PAULMURUGAN, Ramasamy; GHEYSENS, Olivier S et al.Cancer research (Baltimore). 2008, Vol 68, Num 1, pp 216-226, issn 0008-5472, 11 p.Article

P-Glycoprotein-Mediated Resistance to Hsp90-Directed Therapy Is Eclipsed by the Heat Shock ResponseMCCOLLUM, Andrea K; TENEYCK, Cynthia J; STENSGARD, Bridget et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 18, pp 7419-7427, issn 0008-5472, 9 p.Article

Ganetespib and HSP90: Translating Preclinical Hypotheses into Clinical PromisePROIA, David A; BATES, Richard C.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 5, pp 1294-1300, issn 0008-5472, 7 p.Article

Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directionsTONG, David S; BANERJI, Udai; TAVANA, Bahareh et al.Cancer treatment reviews. 2013, Vol 39, Num 4, pp 375-387, issn 0305-7372, 13 p.Article

HSP90 Inhibitor 17-AAG Selectively Eradicates Lymphoma Stem CellsNEWMAN, Bryan; YAN LIU; LEE, Hsiu-Fang et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 17, pp 4551-4561, issn 0008-5472, 11 p.Article

Synergistic AntipancreaticTumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis InhibitorXIANHUA CAO; BLOOMSTON, Mark; DUXIN SUN et al.Clinical cancer research. 2008, Vol 14, Num 6, pp 1831-1839, issn 1078-0432, 9 p.Article